News | December 08, 2011

Accuray Receives Outstanding Innovative Improvement Award for its CyberKnife System

December 8, 2011 – Accuray, a radiation oncology, company, announced that the company received the Outstanding Innovative Improvement Award for its CyberKnife Robotic Radiosurgery System at the 3rd Annual Employer Healthcare Congress, which took place October 25 – 28, 2011 in Chicago.

The award was presented to Accuray in recognition of the fact that patients treated with the CyberKnife System are able to complete treatment in five days or less, compared with radiation therapy treatments, which typically require up to 40 treatment sessions. This significant reduction in the number of daily treatments helps patients get back to work faster, benefitting employees and employers alike. The CyberKnife System targets tumors anywhere in the body and delivers high doses of radiation with pinpoint accuracy. Unlike any other radiation delivery system, the CyberKnife System tracks and adjusts treatment delivery to compensate for tumor motion, including respiration.

"Treatment with the CyberKnife System is typically completed in five or fewer outpatient sessions, compared to the six weeks of daily treatments typical with conventional radiation. Fewer daily treatments allow the employee to get back to their normal schedule, including work, resulting in less stress for the employee and a more efficient workplace for the employer," said Jonathan Edelheit, president of the Employer Healthcare Congress. "Accuray has made a tremendous effort to ensure that employees are aware of the full range of options so they can make an informed treatment decision. We wanted to recognize Accuray's innovative technology, as well as its education efforts with this award."

The Employer Healthcare Congress is among the largest healthcare conferences in the United States. One of the major highlights of the conference is the Leadership Awards given for both excellence in Corporate Wellness and Voluntary Benefits. The Outstanding Innovative Improvement Award honors a company that not only has brought a healthy innovation to employees, but also a cutting-edge approach to changing the way we deal with chronic illness and critical care, all while helping employers reduce healthcare costs.

"Accuray is honored to receive this award from the Employer Healthcare Congress recognizing the advantages that the CyberKnife System offers not only to employees, but employers as well," said Euan S. Thomson, Ph.D., president and chief executive officer of Accuray. "This award reaffirms our commitment to developing personalized, leading-edge treatment solutions that help cancer patients live longer, better lives. This means not only treating their tumors, but also helping them return to their normal lives as soon as possible."

For more information: www.accuray.com

 

Related Content

Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Miami Cancer Institute’s Proton Therapy Center is the first in South Florida and the region’s top destination for this leading-edge treatment. Proton therapy is an advanced form of radiation therapy that uses pencil beam scanning (PBS) technology.

Feature | Proton Therapy | May 27, 2020 | By Minesh Mehta, M.D.
Radiation therapy has advanced significantly in the last few decades as a result of a continued technological revolut
Technology becomes a state-of-the-art tool when it gets exposed to a structure that constantly tests it and allows it to evolve.

Technology becomes a state-of-the-art tool when it gets exposed to a structure that constantly tests it and allows it to evolve. Getty Images

Feature | Oncology Information Management Systems (OIMS) | May 27, 2020 | By Reshu Gupta
In the history of medicine, researchers have found cures for many diseases, but cancer has been elusive.
The global radiation therapy market is expected to reach $10.11 billion in 2024, witnessing growth at a CAGR of 3.38%, over the period 2020-2024.
News | Proton Therapy | May 20, 2020
May 20, 2020 — ResearchAndMarkets.com has released its latest report, the ...
An innovative radiation treatment that could one day be a valuable addition to conventional radiation therapy for inoperable brain and spinal tumors is a step closer, thanks to new research led by University of Saskatchewan (USask) researchers at the Canadian Light Source (CLS).

USask PhD bio-medical engineering student Farley Chicilo at the Canadian Light Source synchrotron at University of Saskatchewan. Photo courtesy of Canadian Light Source, University of Saskatchewan

News | Radiation Therapy | May 14, 2020
May 14, 2020 — An innovative radiation treatment t
Medical University of South Carolina researchers have developed and validated prediction tools, known as nomograms, that could be used to help prevent delays in the initiation of radiotherapy after surgery for head and neck cancer

 

Evan Graboyes, M.D., and his team believe their nomogram tools will improve survival rates for head and neck cancer patients. Photo courtesy of MUSC Hollings Cancer Center

 

News | Radiation Oncology | May 14, 2020
May 14, 2020 — More than 65,000 Americans are diagnosed annually with head and neck cancer, which most often occurs i
Due to ongoing health concerns related to the spread of the Coronavirus (COVID-19) as well as global travel restrictions, the American Association of Physicists in Medicine (AAPM) has decided to evolve the Joint AAPM/COMP (Canadian Organization of Medical Physicists) Meeting content into a virtual (completely online) meeting in place of the in-person meeting originally scheduled for July 12-16, 2020, in Vancouver, BC.
News | AAPM | May 11, 2020
May 11, 2020 — Due to ongoing health concerns related to the spread of the Coronavirus (...
Figure 1: CT image of lesions in different planes

Figure 1: CT image of lesions in different planes.

Sponsored Content | Case Study | Radiation Oncology | April 30, 2020 | By Christopher Bowen, M.S., DABR
360 Photos | 360 View Photos | April 30, 2020
The company .decimal at ASTRO showed a 3-D prin
Two-dimensional (2D) Ruddlesden-Popper phase layered perovskites (BA)2(MA)2Pb3I10 with three layers of inorganic octahedral slab and bulky organics as spacers

Two-dimensional (2D) Ruddlesden-Popper phase layered perovskites (BA)2(MA)2Pb3I10 with three layers of inorganic octahedral slab and bulky organics as spacers. Image courtesy of Dave Tsai/Los Alamos

News | X-Ray | April 24, 2020
April 24, 2020 — Getting an X-ray at the dentist or